TerminatedPhase 3NCT01342705
Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic Cirrhosis
Studying Rare hereditary hemochromatosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Pierre NAHON, MD, PhDAssistance Publique - Hôpitaux de Paris
- Intervention
- phlebotomy(procedure)
- Enrollment
- 17 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2011 – 2014
Study locations (14)
- Amiens University Hospital :, Amiens, France
- Avicenne, Bobigny, France
- Jean Verdier, Bondy, France
- CHU Bordeaux univerity hospital 1, Bordeaux, France
- CHU Bordeaux University hospital 2, Bordeaux, France
- CHU, Caen, France
- Antoine Béclère, Clamart, France
- CHU, Grenoble, France
- CHU, Lille, France
- CHU, Montpellier, France
- CHU, Nancy, France
- CHU, Nice, France
- CHU, Rennes, France
- CHU, Rouen, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01342705 on ClinicalTrials.govOther trials for Rare hereditary hemochromatosis
Additional recruiting or active studies for the same condition.